Dorsal root ganglion (DRG) neurons respond to ATP with transient, persistent or biphasic inward currents. In contrast, the ATP responses in nodose neurons are persistent. These sustained currents are also heterogeneous, with one component being accounted for by P2X 2/3 receptors, and the residual response probably mediated by P2X 2 receptors, although the direct evidence for this has been lacking. In the present study, we examined the P2X receptors on DRG and nodose neurons from P2X 3 -de®cient (P2X 3 ±/± ) mice, using whole cell voltage-clamp recording and immunohistochemistry. We found that all P2X 3 ±/± DRG neurons lacked rapidly desensitizing response to ATP, and both DRG and nodose neurons from P2X 3 -null mutant mice no longer responded to a,b-methylene ATP (abmeATP). In contrast, ATP evoked persistent inward current in 12% of DRG neurons and 84% of nodose neurons from P2X 3 ±/± mice. This retained persistent response to ATP on nodose neurons had an EC 50 for ATP of 77 mM, was antagonized by Cibacron blue and pyridoxal-5-phosphate-6-azophenyl-2¢,4¢-disulphonic acid, potentiated by Zn 2+ and acidi®cation, but not enhanced by ivermectin or diinosine pentaphosphate. 2¢,3¢-O-Trinitrophenyl-ATP antagonized this response with an IC 50 of 8 mM. All these properties are consistent with those of recombinant P2X 2 homomeric receptors. Furthermore, speci®c P2X 2 receptor immunoreactivity detected in wild-type sensory neurons was unaltered in null mutant mice. Therefore, the abmeATP-insensitive persistent responses on nodose neurons are likely to be mediated by P2X 2 homomers, which contribute to 60% of currents evoked by 100 mM ATP in the wild type.
Introduction
P2X receptors are formed from a family of seven homologous subunits (P2X 1±7 ), which can combine to form homomeric and heteromeric receptors (for review see Ralevic & Burnstock, 1998) . In the rat, high levels of P2X 3 expression are found in a subpopulation of primary afferent neurons, including those of dorsal root ganglia (DRG), trigeminal, and nodose ganglia (Chen et al., 1995; Cook et al., 1997; Vulchanova et al., 1997 Vulchanova et al., , 1998 Bradbury et al., 1998) . Intense P2X 3 immunoreactivity is also present in the peripheral and central terminals of these sensory neurons (Cook et al., 1997; Vulchanova et al., 1997 Vulchanova et al., , 1998 Bradbury et al., 1998; Llewellyn-Smith & Burnstock, 1998; Novakovic et al., 1998; Cockayne et al., 2000) . This highly selective expression pattern has led to the view that P2X 3 subunits may play important roles in sensory transmission (see Burnstock, 2000) .
In addition to P2X 3 , low levels of mRNA transcripts and proteins for P2X 1±2 , P2X 4±6 , have also been detected in sensory neurons of the rat (Collo et al., 1996; Xiang et al., 1998) . The colocalization of some of these subunits suggests that mixed populations of receptors may be present in the same neurons, arising from different combinations of P2X subunits (Lewis et al., 1995; Collo et al., 1996; Vulchanova et al., 1997; Barden & Bennett, 2000) . Indeed, the time course of the response to ATP and its analogues in these neurons is quite variable. In trigeminal and DRG neurons, three types of responses have been observed: transient, sustained and biphasic (having both transient and sustained components) (Cook et al., 1997; Burgard et al., 1999; Grubb & Evans, 1999; Li et al., 1999; Ueno et al., 1999; Dunn et al., 2000) . The presence of homomeric P2X 3 receptors and heteromeric P2X 2/3 receptors has been suggested (Burgard et al., 1999; Grubb & Evans, 1999) , although the additional presence of some P2X 2 receptors cannot be excluded. The possibility that some transient responses may be mediated by P2X 1 receptors has also been suggested (Petruska et al., 2000) . In contrast, rat nodose neurons respond to ATP and its analogue a,b-methylene ATP (abmeATP) with sustained responses. However, in these neurons, biphasic inhibition curves were obtained with 2¢,3¢-O-trinitrophenyl-ATP (TNP-ATP), an antagonist which is selective for P2X 1 , P2X 3 and P2X 2/3 receptors. This indicates the presence of multiple receptors most probably formed from P2X 2 and P2X 3 subunits in the forms of 2 n 3 (N±n) , where N = the total number of subunits in the receptor (Thomas et al., 1998) . The lack of subunit selective agonists/ antagonists has so far prevented the direct pharmacological characterization of this mixed population of receptors.
Recently, we have generated P2X 3 -de®cient mice (Cockayne et al., 2000) , to study the roles of P2X receptors containing the P2X 3 subunit. Here, we report the changes in the responses of DRG and nodose neurons after disruption of P2X 3 receptor expression. We have also characterized, using pharmacological and immunohisto-chemical techniques, the P2X receptors retained in nodose neurons of these mutant mice. By removing the major P2X subunits expressed in these neurons, the presence of low levels of other subunits might become more apparent. Preliminary accounts of some of these data have appeared in Abstract form (Zhong et al., 2000a) .
Methods
Generation of P2X 3 knock-out mice P2X 3 -de®cient mice were generated by deleting 1 kb of the P2X 3 gene encompassing exon 1 and the initiating ATG (Cockayne et al, 2000) . Brie¯y, the P2X 3 gene was cloned from a mouse ES-129/Ola P1 genomic library (Genome Systems, St. Louis, MO, USA). The P2X 3 targeting vector included a total of 6.3 kb of genomic sequence, a loxP anked neomycin resistance gene (Neo), and the HSV-TK gene. Homologous recombination between the targeting vector and the wildtype P2X 3 allele results in deletion of a 1.0-kb region of the P2X 3 gene, and replacement of this sequence with the loxP¯anked Neo gene. A Not l linearized targeting vector was electroporated into 129Ola-derived E14-1 embryonic stem cells, and clones were selected in 310 mg/mL active G418 (Gibco BRL, Gaithersburg, MD, USA) and 2 mM gancyclovir (Roche Pharmaceuticals, Nutley, NJ, USA). Southern blot analysis using a 140-bp 5¢¯anking region probe identi®ed positive clones with the predicted 3.0 kb and 1.5 kb EcoRl fragments diagnostic of the wild-type and mutant P2X 3 alleles. Targeted clones were injected into C57BL/6 (Harlan, Indianapolis, IN, USA) blastocysts, and chimeras were established. Germline transmission of the targeted allele was established by mating chimeras to C57BL/6 (Harlan) mice. All mice analyzed in this study have the genetic background 129Ola Q C57BL/6 (Harlan), and were derived from either heterozygous F 1 crosses or homozygous F 2 crosses.
Cell culture
Single neurons from nodose ganglia and DRG of adult wild-type and null mutant mice (6±8-month-old) were enzymatically isolated as described previously (Zhong et al., 1998) . Brie¯y, mice were killed by inhalation of a rising concentration of CO 2 and death was con®rmed by cardiac haemorrhage. The nodose ganglia and DRG were rapidly dissected out, and placed in Leibovitz's L-15 medium (Life Technologies, Paisley, UK). The ganglia were then desheathed, cut and incubated in 4 mL Ca 2+ /Mg 2+ -free Hanks' Balanced Salt Solution with 10 mM HEPES buffer (pH 7.0) (HBSS; Life Technologies) containing 1.5 mg/ml collagenase (Class-II, Worthington Biochemical Corporation, Reading, UK) and 6 mg/ml bovine serum albumin (Sigma, Poole, UK) at 37°C for 40 min. The ganglia were then incubated with 4 mL HBSS containing 1 mg/ml trypsin (Sigma) at 37°C for 20 min. The solution was replaced with 3 mL growth medium comprising of L-15 medium supplemented with 10% bovine serum, 50 ng/ml nerve growth factor, 0.2% NaHCO 3 , 5.5 mg/ml glucose, 200 IU/ml penicillin and 200 mg/ml streptomycin. The ganglia were dissociated into single neurons by gentle trituration. The cells were then centrifuged at 160 g (900 r.p.m.) for 5 min, resuspended in 1 mL growth medium and plated onto 35-mm Petri dishes coated with 10 mg/ml laminin (Sigma). Cells were maintained at 37°C in a humidi®ed atmosphere containing 5% CO 2 , and used after 2±48 h.
Electrophysiology
Whole cell voltage-clamp recording was carried out at room temperature using an Axopatch 200B ampli®er (Axon Instruments, Foster City, CA, USA). Membrane potential was held at ±60 mV.
External solution contained (mM): NaCl 154, KCl 4.7, MgCl 2 1.2, CaCl 2 2.5, HEPES 10, glucose 5.6, the pH was adjusted to 7.4 using NaOH. Recording electrodes (resistance 2±4 MW) were ®lled with internal solution which contained (mM): citric acid 56, MgCl 2 3, CsCl 10, NaCl 10, HEPES 40, EGTA 0.1, tetraethylammonium chloride 10, and the pH adjusted to 7.2 using CsOH (total Cs + concentration 170 mM). The composition of this solution was chosen to minimize complications arising from the secondary activation of any potassium or chloride currents. Series resistance compensation of 72±75% was used in all recordings. The threshold for minimum response detectable was set as 20 pA. Data were acquired using pCLAMP software (Axon Instruments). Signals were ®ltered at 2 kHz (±3 dB frequency, Bessel ®lter, 80 dB/decade).
For nodose neurons, drugs were applied by gravity¯ow from independent reservoirs through a 7-barrel manifold comprising fused glass capillaries inserted into a common outlet tube (tip diameter of 200 mm) which was placed approximately 200 mm from the cell (Dunn et al., 1996) . One barrel was used to apply drug-free solution to enable rapid termination of drug application. Solution exchange measured by changes in open tip current was complete in 200 ms; however, complete exchange of solution around an intact cell was considerably slower (`1 s). For DRG neurons, drugs were applied through a similar 4-barrel manifold, controlled by computer driven solenoid valves. The exchange of solution around the cell was complete in`100 ms. The intervals between agonist application were 2 min for nodose, and 3.5 min for DRG neurons, respectively, which were suf®cient to achieve reproducible responses.
All data are expressed as the mean T SEM. Statistical analysis (Student's t-test) was performed using Prism v2 (Graphpad, San Diego, CA, USA). Concentration-response data were ®tted with the Hill equation:
, where A is the maximum effect, K is the EC 50 , and n is the Hill coef®cient, using Prism v2, Graphpad. The combined data from the given number of cells were ®tted, and the results are presented as values T SE, determined by the ®tting routine. Traces were acquired using Fetchex (pCLAMP software) and plotted using Origin (Microcal, Northampton, MA, USA). ATP, abmeATP and Cibacron blue were obtained from Sigma Chemical Co (Poole, UK). Pyridoxal-5-phosphate-6-azophenyl-2¢,4¢-disulphonic acid was purchased from Tocris Cookson Ltd (Bristol, UK). 2¢,3¢-OTrinitrophenyl-ATP was obtained from Molecular Probes (Leiden, Netherlands). Solutions (10 and 100 mM) of ATP and other drugs were prepared using deionized water and stored frozen. All drugs were then diluted in extracellular bathing solution to the ®nal concentration.
Immunohistochemistry
Adult wild-type and null mutant mice were killed as described above and the nodose and DRG were dissected out. These ganglia were rapidly frozen by immersion in isopentane at ±70°C for 2 min. The sections were cut to 10 mm thickness using a cryostat, thaw-mounted on gelatine-coated slides and air-dried at room temperature.
Polyclonal antisera for P2X 1±7 receptors were generated and characterized as previously described Oglesby et al., 1999) . Antibodies against rat P2X 1±6 receptors were applied to the tissue and visualized using the avidin-biotin (ABC) technique (Llewellyn-Smith et al., 1993; Zhong et al., 1998) . Brie¯y, the sections were ®xed in 4% formaldehyde (in 0.1 M phosphate buffer) containing 0.03% picric acid (pH 7.4) for 10 min. Endogenous peroxidase was blocked with 50% methanol containing 0.4% hydrogen peroxide (H 2 O 2 ) for 10 min. Non-speci®c binding was blocked by a 20-min incubation with 10% normal horse serum (NHS) (Life Technologies) in phosphate-buffered saline (PBS) containing 0.05% merthiolate (Sigma). The sections were incubated with the primary antibodies P2X receptors in P2X 3 knock-out mice 1785 diluted to 2.5 mg/ml (determined as optimal by previous titrations) with 10% NHS in PBS containing 0.05% Merthiolate overnight. Subsequently the sections were incubated with biotinylated donkey antirabbit IgG (Jackson Immunoresearch, PA. USA) diluted 1 : 500 in 1% NHS in PBS containing 0.05% Merthiolate for 1 h, followed by the incubation with ExtrAvidin-horseradish peroxidase (Sigma) diluted 1 : 1500 in PBS containing 0.05% Merthiolate for 1 h. All incubations were held at room temperature and separated by 3 Q 5-min washes in PBS. Finally, freshly prepared colour reaction mixture containing 0.5% 3,3¢-diaminobenzidine, 0.1 M sodium phosphate, 0.004% NH 4 Cl, 0.2% glucose, 0.04% nickel ammonium sulphate and 0.1% glucose oxidase were applied to the sections for 5 min. The sections were then washed, dehydrated, cleared in xylene and mounted using Eukitt (BDH, Poole, UK).
Results

Immunohistochemistry
Antibodies raised against the C-terminus of rat P2X 1±6 subunits were used on mouse DRG and nodose ganglia. Strong P2X 3 immunoreactivity was observed in many small diameter neurons in DRG and nodose ganglia of wild-type mice ( Fig. 1A and E). Less intense staining was present in medium diameter neurons, while most large cells showed little P2X 3 immunoreactivity. In sensory ganglia from P2X 3 knockout mice, speci®c P2X 3 -immunostaining was totally absent (Fig. 1B and F) . Speci®c membrane-bound P2X 2 immunoreactivity was present in many DRG and nodose neurons from the wild-type mice ( Fig. 1C and G ) and appeared to be qualitatively unchanged in the null mutant ( Fig. 1D and H) . In addition, P2X 5 and P2X 6 immunoreactivity was present in similarly low levels in DRG and nodose ganglia from wild-type and mutant mice (data not shown), while immunoreactivity for P2X 1 , P2X 4 or P2X 7 was not detected in mouse sensory ganglia (data not shown).
Electrophysiology
DRG neurons
In wild-type mice, 10 mM ATP evoked a rapidly desensitizing inward current in 42% (26/61) of neurons, with the average amplitude being 0.41 T 0.09 nA ( Fig. 2A) . In 21% (13/61) of neurons, ATP evoked a sustained current of 0.51 T 0.19 nA (Fig. 2B) . A further 5% (3/61) of neurons gave biphasic responses with both transient and sustained components. Comparable transient, sustained or biphasic responses were evoked in these neurons by 30 mM abmeATP. All P2X 3 +/+ neurons tested (40/40) responded to 100 mM g-aminobutyric acid (GABA); while 31% (9/29) responded to 5 mM capsaicin. There did not appear to be any correlation between sensitivity to capsaicin and ATP.
In the P2X 3 -de®cient mice, application of either ATP (10±300 mM) or abmeATP (30±100 mM) failed to produce a rapidly desensitizing inward current in DRG neurons (49 cells tested) (Fig. 2C) . Sustained responses to ATP were observed in 12% (6/49) of neurons, while no slowly desensitizing response was evoked by 30 mM abmeATP (Fig. 2D) . As in wild-type neurons, all cells tested (41/41) responded to 100 mM GABA, and 23% (6/26) responded to 5 mM capsaicin.
Nodose neurons
Whole cell responses. In wild-type mice, of the 46 nodose neurons tested with both ATP and abmeATP (10±100 mM), 96% (44/46) responded to ATP, and 43/46 of the cells also responded to abmeATP. Amongst the cells that responded to both agonists, 39 neurons gave a persistent response, one cell gave a transient response, and three cells gave biphasic responses with both transient and sustained components (Fig. 3A and B) . The amplitude of the persistent response to 100 mM ATP was 5.2 T 0.5 nA (mean T SEM, n = 25), which was signi®cantly greater than the response to 100 mM abmeATP (3.1 T 0.4 nA, n = 18, P < 0.05).
In null mutant mice, none of the nodose neurons tested (n = 12) responded to 100 mM abmeATP, yet they all gave a persistent response to 30 mM ATP (Fig. 3C) . The proportion of neurons responding to ATP (43/51, 84%) was not signi®cantly different (P > 0.1) from that of the wild type. However, the mean amplitude of the persistent response to 100 mM ATP (3.2 T 0.6 nA, n = 26) was signi®cantly (P < 0.05) smaller than that observed for P2X 3 +/+ neurons (5.2 T 0.5 nA).
These results indicate that mixed populations of P2X receptors are present on wild-type mouse nodose neurons. Consequently, in P2X 3 +/+ nodose neurons, abmeATP evoked a signi®cantly lower maximum response than that of ATP, and the disruption of the P2X 3 gene only reduced the amplitude of the ATP response by 40%. This suggests that a signi®cant proportion of the ATP current in wild-type nodose neurons is mediated through an abmeATP-insensitive receptor. Hence, we sought to examine the pharmacological properties of this abmeATP-insensitive receptor present in P2X 3 ±/± nodose neurons.
Concentration-response curves for agonists. Rapid application of ATP, but not abmeATP, evoked persistent responses in P2X 3 ±/± nodose neurons. Fitting the Hill equation to the concentration± response relationship for ATP yielded an EC 50 of 77 mM (log EC 50 = ±4.11 T 0.04, n = 5) and a Hill coef®cient of 2.1 (Fig. 4) .
In wild-type mice, the concentration±response curve for abmeATP on nodose neurons had an EC 50 of 35 mM (logEC 50 = ±4.45 T 0.07, n = 5), and a Hill coef®cient of 1.5 (Fig. 4) . As ATP activated at least two populations of P2X receptors on P2X 3 +/+ nodose neurons, we attempted to ®t its concentration±response curve with the twocomponent Hill equation, assuming equal proportions of both components. Using the EC 50 value for one component of 77 mM (as previously determined from the P2X 3 ±/± neurons), this gave an EC 50 for the second component of 12 mM (n = 5).
Effect of antagonists. Cibacron blue is a potent antagonist of neuronal P2X 2 receptors (Zhong et al., 1998) . In P2X 3 ±/± nodose neurons, the response to ATP (30 mM) was inhibited by Cibacron blue (10 mM) to 11 T 1% of the control (n = 5), after a 2-min preincubation. The response recovered to 107 T 10% of the control (n = 4) 2 min after washing out the antagonist (Fig. 5A and B) .
Pyridoxal-5-phosphate-6-azophenyl-2¢,4¢-disulphonic acid (PPADS) produced a time-and concentration-dependent antagonism of the response to ATP at neuronal P2X 2 receptors (Zhong et al., 1998) . In P2X 3 ±/± nodose neurons, following a 4-min preincubation with 1 mM of PPADS, the response to ATP was reduced by approximately 40%. In the presence of 10 mM PPADS, the response to ATP was almost completely abolished (Fig. 5C ). There was little recovery 4 min after washing to remove PPADS (n = 4).
The P2X antagonist 2¢,3¢-O-trinitrophenyl-ATP (TNP-ATP) displays 1000 fold higher potency on recombinant P2X 1 , P2X 3 and P2X 2/3 receptors over P2X 2 receptors Dunn et al., 2000) . On P2X 3 +/+ nodose neurons, TNP-ATP inhibited the response to abmeATP (30 mM) with an IC 50 of 11 T 2 nM (n = 4, Fig. 6 ). In contrast, the response evoked by ATP (30 mM) from P2X 3 ±/± nodose neurons was approximately 1000 times less sensitive to TNP-ATP (IC 50 = 7.9 T 0.8 mM, n = 4). We then tested the sensitivity of the ATP response in wild-type neurons to 1 mM TNP-ATP (a concentration which abolished the response to abmeATP in P2X 3 +/+ neurons, but had no effect on the ATP response in P2X 3 ±/± neurons). In agreement with the ®ndings of Thomas et al. (1998) studying rat nodose neurons, this concentration of TNP-ATP produced some antagonism, but the extent of the inhibition varied considerably from cell to cell (between 25 and 75%, n = 4).
FIG. 1. P2X 2 and P2X 3 immunoreactivity in mouse sensory ganglia. Dorsal root (A±D) and nodose ganglia (E±H) sections from wild-type (A, C, E and G) and P2X 3 -null mutant (B, D, F and H) mice were examined using antibodies raised against peptide sequences of the C-termini of rat P2X 2 or P2X 3 subunits. Speci®c P2X 3 immunoreactivity was observed in sensory ganglion neurons of wild-type mice, with many small diameter neurons showing intense labelling (A and E). This P2X 3 immunoreactivity was absent in P2X 3 -de®cient mice (B and F). By contrast, the speci®c P2X 2 immunoreactivity seen in many wildtype DRG and nodose ganglia (C and G) remained unchanged in P2X 3 ±/± mice (D and H). Scale bar, 50 mm.
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Effect of allosteric modulators. Zn 2+ and H + have potent modulatory effects on some P2X receptors (for review see North & Surprenant, 2000) . On P2X 3 ±/± nodose neurons, coapplication of Zn 2+ (10 mM) enhanced the response to ATP (30 mM) to 224 T 15% of the control (n = 5), and its effect was completely reversible. Lowering the extracellular pH from 7.4 to 6.8 potentiated the response to 30 mM ATP to 229 T 15% of the control (n = 5), and shifted the concentration±response curve for ATP to the left by approximately 0.26 log unit. This was similar to the shift produced by 10 mM Zn 2+ (data not shown).
The action of ATP at receptors containing the P2X 4 subunit can be selectively potentiated by ivermectin (Khakh et al., 1999) and diinosine pentaphosphate (Ip 5 I) . After a 2-min preincubation with 1 mM ivermectin, the currents evoked by ATP (100 mM) on P2X 3 ±/± nodose neurons were 99 T 1% of the control (n = 5). Similarly, after a 2-min preincubation with 1 mM Ip 5 I, the response to 100 mM ATP was reduced to 92 T 2% of the control (n = 6, P < 0.01).
Discussion
Evidence from molecular biology and immunohistochemistry indicate that most P2X subunits are present in sensory neurons (see Dunn et al., 2001 for review). However, functional experiments suggest only a few of these subunits are important. Thus in DRG neurons, the homomeric P2X 3 receptor appears to predominate. In nodose ganglion neurons at least two distinct receptors are present, one activated by abmeATP, and hence thought to be the heteromeric P2X 2/3 receptor, the other is insensitive to this agonist and may be the P2X 2 homomer. However, the lack of a selective agonist for this receptor has prevented its direct characterization when it coexists with the P2X 2/3 receptor. In the present study, using P2X 3 -null mutant mice, we have been able to examine the pharmacological properties of the abmeATP-insensitive component directly. In addition, we speculated that by deleting one of the major P2X subunits, functional evidence for the presence of other subunits might become more apparent.
Con®rmation of the absence of the P2X 3 subunit in null mutant mice
In P2X 3 -null mutant mice, P2X 3 immunoreactivity is undetectable in DRG, nodose ganglia, spinal cord and the peripheral terminals of sensory neurons ( Fig. 1 ; also see Cockayne et al., 2000) . However, neurons that normally express P2X 3 are still present with qualitatively similar distribution and patterns of innervation, both peripherally and centrally (Cockayne et al., 2000) . The absence of P2X 3 expression is further con®rmed by our functional experiments. No DRG neurons from P2X 3 ±/± mice responded to ATP with rapidly desensitizing currents, and neither nodose nor DRG neurons from P2X 3 ±/± mice showed any responsiveness to abmeATP.
P2X 3
±/± nodose neurons retain a P2X 2 -like receptor
The mouse P2X subtypes cloned to date, P2X 3, P2X 4 and P2X 5 , show > 94% identity with rat orthologues at the protein level (Souslova et al., 1997; Townsend-Nicholson et al., 1999; Cox et al., 2001 ) and appear to exhibit almost identical pharmacological properties. We have previously shown that autonomic ganglion neurons from both rat and mouse possess P2X receptors that exhibit identical pharmacological properties, which are consistent with those of the rat P2X 2 homomeric receptor (Zhong et al., 2000b) . Although some caution is advisable in making direct comparison between the native receptors in the mouse and recombinant rat P2X (rP2X) receptors, the great similarity observed between mouse and rat P2X orthologues permits us to use currently available pharmacological tools (best characterized on rP2X receptors) to study the endogenous P2X receptors in the mouse.
In P2X 3 ±/± mice, many nodose neurons show speci®c P2X 2 receptor immunoreactivity (Fig. 1) , with no detectable levels of P2X 1,3,4,7 and only low levels of P2X 5 and P2X 6 . In functional experiments, ATP activates a slowly desensitizing inward current with an EC 50 of 77 mM, while abmeATP is inactive. These properties are generally in keeping with those of the rP2X 2 homomeric receptor (Brake et al., 1994) . Although the EC 50 value we obtained for ATP is slightly higher than that of 43 mM obtained for SCG neurons by Khakh et al. (1995) , there is a wide range of values reported for recombinant P2X 2 receptors, ranging from 4 mM (Liu et al., 2001 ) to 60 mM (Brake et al., 1994) . ±/± nodose neurons gave an EC 50 value of 77 mM and a Hill coef®cient of 2.1. In P2X 3 +/+ nodose neurons, the concentration±response curve for abmeATP had an EC 50 of 35 mM, and a Hill coef®cient of 1.5, while that for ATP was ®tted with the twocomponent Hill equation, having EC 50 values of 12 mM and 77 mM (see text for details). Responses to abmeATP and ATP were normalized to that of 300 mM abmeATP and 1 mM ATP, respectively. Each data point represents the mean T SE of 4 or 5 cells.
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The ATP response on P2X 3 ±/± nodose neurons was strongly inhibited by both Cibacron blue and PPADS (10 mM), which are potent antagonists of rat neuronal P2X 2 receptors (Zhong et al., 1998 (Zhong et al., , 2000b . In addition, the response was potentiated by Zn 2+ in a similar way to that observed on recombinant rP2X 2 receptors (Wildman et al., 1998) . TNP-ATP inhibited the ATP response in P2X 3 ±/± nodose neurons with an IC 50 of 8 mM, which is similar to the value reported for rP2X 2 . Extracellular pH is another tool for discriminating between recombinant P2X receptors, with P2X 2 and to a lesser extent P2X 2/3 and P2X 2/6 receptors being selectively potentiated by acidi®cation (King et al., 1997; Stoop et al., 1997; Wildman et al., 1999; King et al., 2000) . The response to ATP on P2X 3 ±/± nodose neurons was signi®cantly potentiated by the reduction of pH from 7.4 to 6.8. Thus, the sensitivity to pH is again consistent with these currents being accounted for by P2X 2 homomers. To further rule out the involvement of P2X 4 subunit, we tested the effect of ivermectin and Ip 5 I. Ivermectin is a selective potentiator of P2X 4 and P2X 4/6 receptors (with an EC 50 close to 1 mM), while it is inactive on P2X 2 receptors at concentrations up to 10 mM (Khakh et al., 1999) . Ip 5 I, a potent antagonist on P2X 1 and P2X 3 receptors, potentiates P2X 4 receptors with an EC 50 around 3 nM, yet is inactive on P2X 2 at concentrations up to 30 mM . On P2X 3 ±/± nodose neurons, neither ivermectin nor Ip 5 I (1 mM) produced any enhancement of the ATP response. Thus the ATP response on P2X 3 ±/± nodose neurons is unlikely to be mediated by P2X 4 or P2X 4/6 receptors. This is consistent with the absence of P2X 4 immunoreactivity on mouse sensory ganglia. The detection of low levels of P2X 5 and P2X 6 immunoreactivity raises the possibility that they may also be involved. However, receptors formed from P2X 6 subunits are unlikely because they are resistant to PPADS (Collo et al., 1996) , yet the ATP response of P2X 3 ±/± nodose neurons was blockable by PPADS. The properties of P2X 5 receptors are similar to that of P2X 2 receptors, making it much harder to exclude. Furthermore, the involvement of these subunits in some heteromeric receptors cannot be ruled out. Nevertheless, the simplest explanation which our data would support, is that the response present in P2X 3 ±/± neurons is mediated by homomeric P2X 2 receptors.
Identity of P2X receptors in wild-type mouse nodose and DRG neurons
In P2X 3 +/+ nodose neurons, the slowly desensitizing current evoked by abmeATP is consistent with it being conducted by P2X 2/3 heteromeric receptors. This is further supported by the P2X 2 -and P2X 3 -immunoreactivity observed in these ganglia, and is similar to the situation in rat nodose neurons (Lewis et al., 1995) . In addition, the sensitivity of the abmeATP response to TNP-ATP is similar to that of recombinant P2X 2/3 receptors. In wild-type nodose ganglion neurons, ATP activated an additional population of abmeATPinsensitive receptors, which was much less sensitive to the antagonist TNP-ATP. We speculate that this is the same receptor that is retained in the P2X 3 ±/± ganglia and which clearly has the phenotype of the P2X 2 homomer. This suggests that mouse nodose neurons contain signi®cant proportions of both homomeric P2X 2 and heteromeric P2X 2/3 receptors. Occasionally, we also observed biphasic or transient responses to ATP in approximately 10% of P2X 3 +/+ nodose neurons. Although both P2X 1 and P2X 3 homomers may contribute to this transient response, the lack of any detectable P2X 1 immunoreactivity and the absence of transient response in P2X 3 ±/± nodose neurons strongly suggests that P2X 1 is not involved in the mouse nodose ganglion.
The three types of currents evoked by ATP in wild-type mouse DRG neurons are very similar to those observed in rat DRG neurons (Burgard et al., 1999; Grubb & Evans, 1999) . Whereas the presence of P2X 3 homomers and P2X 2/3 heteromers has been suggested in the rat, it is not clear whether P2X 2 homomers are also present. In P2X 3 ±/± DRG neurons, while the rapidly desensitizing response and the sensitivity to abmeATP are no longer present, approximately 10% cells still responded to ATP with a slowly desensitizing pro®le. Due to the scarcity of cells showing this type of response, we have not characterized it pharmacologically. However, the available functional and immunohistochemical evidence is consistent with it being the homomeric P2X 2 receptor. Thus, in wild-type mouse DRG, in addition to P2X 3 homomers and P2X 2/3 heteromers, P2X 2 homomers may also be present at a low level in a small percentage of neurons.
It has been suggested that P2X 1 receptors may be responsible for a component of the transient ATP response in some DRG neurons (Petruska et al., 2000) . Although we cannot rule out the possibility of interspecies differences, or age-dependent changes in receptor expression, the absence of any transient responses in P2X 3 ±/± mice would argue strongly against this.
Are there compensatory changes?
It is possible that some compensatory changes may occur after the disruption of P2X 3 gene expression. We found that responses to GABA and capsaicin appeared to be qualitatively unchanged in P2X 3 -null mutants, and P2X 2 immunoreactivity appeared unaltered in P2X 3 ±/± neurons. The amplitude of the response to 100 mM ATP in P2X 3 ±/± nodose neurons (3.2 nA), was smaller than that in the wild-type neurons, consistent with a loss of P2X 2/3 heteromeric receptors. However, the response was slightly greater than that mediated by the abmeATP-insensitive receptors in wildtype cells (determined from the difference between the response to ATP and abmeATP to be 2.1 nA), suggesting that there might be a slight increase in the number of homomeric P2X 2 receptors present. Nevertheless, this did not reach statistical signi®cance. Thus there do not appear to be any signi®cant compensatory changes resulting from the null mutation of the P2X 3 gene, at least in 6±8-month-old mice. FIG. 6 . Concentration inhibition curves by TNP-ATP of agonist responses on nodose neurons of wild-type and P2X 3 -null mutant mice, using abmeATP (30 mM) or ATP (30 mM) as the agonist, respectively. TNP-ATP displayed IC 50 values of 11 nM and 7.9 mM on these two populations of P2X receptors, respectively. In nodose neurons from wild-type mice, the response to ATP (30 mM) was partially inhibited but not abolished by TNP-ATP (1 mM), following a 2-min preincubation. Each data point represents the mean T SE from 4 or 5 cells.
Implications of ®ndings from P2X 3 -null mutant mice Extracellular ATP has been implicated in numerous sensory processes (Burnstock, 2000) . Studies on P2X 3 -de®cient mice have pointed out important physiological roles of P2X 3 -containing receptors in afferent pathways controlling urinary bladder volume re¯exes, temperature sensing, and in¯ammatory pain states (Cockayne et al., 2000; Souslova et al., 2000) . As a signi®cant number of P2X 2 and P2X 2/3 receptors are also present in some sensory neurons including those of the nodose ganglia, it will be important to establish the roles of these other P2X receptors.
